Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation.

Weinberger AH, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, George TP.

J Clin Psychopharmacol. 2009 Dec;29(6):601-3. doi: 10.1097/JCP.0b013e3181bfd0b4. No abstract available.

2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
3.

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.

Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW.

J Clin Psychiatry. 2012 Jan;73(1):95-102. doi: 10.4088/JCP.10m06143gre. Epub 2011 Apr 5.

PMID:
21535998
4.

Long term effects of smoking cessation in hospitalized schizophrenia patients.

Miyauchi M, Kishida I, Suda A, Shiraishi Y, Fujibayashi M, Taguri M, Ishii C, Ishii N, Moritani T, Hirayasu Y.

BMC Psychiatry. 2017 Mar 7;17(1):87. doi: 10.1186/s12888-017-1250-1.

5.

Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N.

Psychopharmacology (Berl). 2011 Sep;217(2):279-87. doi: 10.1007/s00213-011-2282-8. Epub 2011 Apr 8.

6.

Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.

Rovina N, Nikoloutsou I, Katsani G, Dima E, Fransis K, Roussos C, Gratziou C.

Ther Adv Respir Dis. 2009 Dec;3(6):279-87. doi: 10.1177/1753465809350653.

PMID:
19934280
7.

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program.

Mann-Wrobel MC, Bennett ME, Weiner EE, Buchanan RW, Ball MP.

Schizophr Res. 2011 Mar;126(1-3):277-83. doi: 10.1016/j.schres.2010.10.030. Epub 2010 Nov 26.

PMID:
21112185
8.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
9.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
10.

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1184-90.

PMID:
16187778
11.

Pilot Cases of Combined Cognitive Processing Therapy and Smoking Cessation for Smokers With Posttraumatic Stress Disorder.

Dedert EA, Resick PA, McFall ME, Dennis PA, Olsen M, Beckham JC.

Behav Ther. 2016 Jan;47(1):54-65. doi: 10.1016/j.beth.2015.09.002. Epub 2015 Sep 25.

12.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
13.

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

J Clin Psychopharmacol. 2005 Jun;25(3):218-25.

PMID:
15876899
14.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.

Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.

Nicotine Tob Res. 2001 Nov;3(4):397-403.

PMID:
11694208
15.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
16.

Coping with urges to smoke: what is a clinician to do?

Modesto-Lowe V, Chmielewska A.

Conn Med. 2013 May;77(5):289-94. Review.

PMID:
23777042
17.

Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation.

Gifford EV, Kohlenberg BS, Hayes SC, Pierson HM, Piasecki MP, Antonuccio DO, Palm KM.

Behav Ther. 2011 Dec;42(4):700-15. doi: 10.1016/j.beth.2011.03.002. Epub 2011 May 25.

PMID:
22035998
18.

Smoking cessation in severe mental illness: what works?

Banham L, Gilbody S.

Addiction. 2010 Jul;105(7):1176-89. doi: 10.1111/j.1360-0443.2010.02946.x. Epub 2010 May 11. Review.

PMID:
20491721
19.

Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.

Steinberg MB, Bover MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J.

Drug Alcohol Depend. 2011 Mar 1;114(1):77-81. doi: 10.1016/j.drugalcdep.2010.06.022. Epub 2010 Oct 16.

PMID:
20951511
20.

Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention.

Wittchen HU, Hoch E, Klotsche J, Muehlig S.

Int J Methods Psychiatr Res. 2011 Mar;20(1):28-39. doi: 10.1002/mpr.328.

PMID:
21574208

Supplemental Content

Support Center